Long-term outcomes and prognostic factors in generalized myasthenia gravis
Long-term outcomes and prognostic factors in generalized myasthenia gravis
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Objective
This study aimed to investigate the timing of meeting the criteria for a status of “minimal manifestation (MM) or better” and the factors that influenced whether “MM or better status” or “MM or better status with an oral prednisolone (PSL) dose of 5 mg/day or less (5-mg MM)” was met in patients with acetylcholine receptor (AChR) antibo...
Alternative Titles
Full title
Long-term outcomes and prognostic factors in generalized myasthenia gravis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2506508846
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2506508846
Other Identifiers
ISSN
0340-5354
E-ISSN
1432-1459
DOI
10.1007/s00415-021-10520-x
